References
- Alpert B. S., Gilman P. A., Strong W. B., Ellison M. F., Miller M. D., McFarlane J., Hayashidera T. Hemodynamic and ECG responses to exercise in children with sickle cell anemia. American Journal of Diseases of Children 1981; 135: 362–366
- Bakker E. N., Linden P. J., Sipkema P. Endothelin-1-induced constriction inhibits nitric-oxide-mediated dilation in isolated rat resistance arteries. Journal of Vascular Research 1997; 34: 418–424
- Bourantas K. L., Dalekos G. N., Makis A., Chaidos A., Tsiara S., Mavridis A. Acute phase proteins and interleukins in steady state sickle cell disease. European Journal of Haemarology 1998; 61: 49–54
- Bunn H. F. Pathogenesis and treatment of sickle cell disease. New England Journal of Medicine 1997; 337: 762–769
- Bruunsgaard H., Galbo H., Halkjaer-Kristensen J., Johansen T. L., MacLean D. A., Pedersen B. K. Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage. Journal of Physiology (London) 1997; 499: 833–841
- Clarkson P., Montgomery H. E., Mullen M. J., Donald A. E., Powe A. J., Bull T., Jubb M., World M., Deanfield I. E. Exercise training enhances endothelial function in young men. Journal of the American College of Cardiology 1999; 33: 1379–1385
- Covitz W., Eubig C., Balfour I. C., Jerath R., Alpert B. S., Strong W. B., DuRant R. H. Exercise-induced cardiac dysfunction in sickle cell anemia. A radionuclide study. American Journal of Cardiology 1983; 51: 570–575
- Gellai M., De Wolf R., Fletcher T., Nambi P. Contribution of endogenous endithelin-1 to the maintenance of vascular tone: role of nitric oxide. Pharmacology 1997; 55: 299–308
- Graido-Gonzalez E., Doherty J. C., Bergreen E. W., Organ G., Telfer M., McMillen M. A. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood 1998; 92: 2551–2555
- Green D. J., O'Driscoll G., Blanksby B. A., Taylor R. R. Control of skeletal muscle blood flow during dynamic exercise: contribution of endothelium-derived nitric oxide. Sports Medicine 1996; 21: 119–146
- Hedo C. C., Aken'ova Y. A., Okpala I. E., Durojaiye A. O., Salimonu L. S. Acute phase reactants and severity of homozygous sickle cell disease. Journal of Internal Medicine 1993; 233: 467–470
- Ikeda U., Yamamoto K., Maeda Y., Shimpo M., Kanbe T., Shimada K. Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 1997; 29: 65–69
- Kasschau M. R., Barabino G. A., Bridges K. R., Golan D. E. Adhesion of sickle neutrophils and erythrocytes to fibronectin. Blood 1996; 87: 771–780
- Kuvibidila S., Gardner R., Ode D., Yu L., Lane G., Warrier R. P. Tumor necrosis factor alpha in children with sickle cell disease in stable condition. Journal of the National Medical Association 1997; 89: 609–615
- Lin Z., Kubota T., Masuda M., Aso T. Role of nitric oxide synthase in release of endothelin from cultured human endometrial cells. European Journal of Endocrinology 1998; 138: 467–471
- Lopez B. L., Barnett J., Ballas S. K., Christopher T. A., Davis-Moon L., Ma X. Nitric oxide metabolite levels in acute vaso-occlusive sickle-cell crisis. Academy of Emergency Medicine 1996; 3: 1098–1103
- Maeda S., Miyauchi T., Sakane M., Saito M., Maki S., Goto K., Matsuda M. Does endothelin-1 participate in the exercise-induced changes of blood flow distribution of muscles in humans. Journal of Applied Physiology 1997; 82: 1107–1111
- Mahler D. A., Froelicher V. F., Houston Miller N., York T. D. ACSM's Guidelines for Exercise Testing and Prescription. Williams & Wilkins, Media, PA. 1995
- Malave I., Perdomo Y., Escalona E., Rodriguez E., Anchustegui M., Malave H., Arends T. Levels of tumor necrosis factors alpha/cachetin (TNF alpha) in sera from patients with sickle cell disease. Acta Haematologica 1993; 90: 172–176
- Miller D. M., Winslow R. M., Klein H. G., Wilson K. C., Brown F. L., Statham N. J. Improved exercise performance after exchange transfusion in subjects with sickle cell anemia. Blood 1980; 56: 1127–1131
- Millis R. M., Baker E. W., Ertugrul L., Douglas R. M., Sexcius L. Physical performance decrements in children with sickle cell anemia. Journal of the National Medical Association 1994; 86: 113–116
- Mollapour E., Porter J. B., Kaczmarski R., Linch D. C., Roberts P. J. Raised neutrophil phospholipase A2 activity and defective priming of NADPH oxidase and phospholipase A2 in sickle cell disease. Blood 1998; 91: 3423–3429
- Moore C., Ehlayel M., Inostroza J., Leiva L. E., Kuvibidila S., Yu L., Gardner R., Ode D. L., Warrier R., Sorensen R. U. Increased circulating levels of soluble HLA class I heterodimers in patients with sickle cell disease. Journal of the National Medical Association 1998; 90: 157–163
- Northoff H., Weinstock C., Berg A. The cytokine response to strenuous exercise. International Journal of Sports Medicine 1994; 15(Suppl 3): S167–S171
- Painter P., Blackburn G. Exercise for patients with chronic disease. Postgraduate Medicine 1988; 83: 185–196
- Pedersen B. K., Ostrowski K., Rhode T., Bruunsgaard H. The cytokine response to strenuous exercise. Canadian Journal of Physiology and Pharmacology 1998; 76: 505–511
- Pianosi P., D'Souza S. J., Esseltine D. W., Charge T. D., Coates A. L. Ventilation and gas exchange during exercise in sickle cell anemia. American Review of Respiratory Diseases 1991; 143: 226–230
- Pollock D. M. Chronic studies on the interaction between nitric oxide and endothelin in cardiovascular and renal function. Clinical and Experimental Pharmacology and Physiology 1999; 26: 258–261
- Predel H. G., Knigge H., Prinz U., Kramer H. J., Stalleicken D., Rost R. E. Exercise increases endothelin-1 plasma concentrations in patients with coronary artery disease: modulatory role of LDL cholesterol and of pentaerithrityltetranitrate. Journal of Cardiovascular Pharmacology 1995; 26: S497–S501
- Rees D. C., Cervi P., Grimwade D., O'Driscoll A., Hamilton M., Parker N. E., Porter J. B. The metabolites of nitric oxide in sickle-cell disease. British Journal of Haematology 1995; 91: 834–837
- Rivier A., Pene J., Anselme F., Caillaud C., Prefaut C., Godard P., Bousquet J. Release of cytokines by blood monocytes during strenuous exercise. International Journal of Sports Medicine 1994; 15: 192–198
- Rybicki A. C., Benjamin L. J. Increased levels of endothelin-1 in plasma of sickle cell anemia patients. Blood 1998; 92: 2594–2596
- Shen W., Zhang X., Zhao G., Wolin M. S., Sessa W., Hintze T. H. Nitric oxide production and NO synthase gene expression contribute to vascular regulation during exercise. Medicine and Science in Sports and Exercise 1995; 27: 1125–1134
- Singhal A., Doherty J. F., Raynes J. G., McAdam K. P., Thomas P. W., Serjeant B. E., Serjeant G. R. Is there an acute-phase response in steady-state sickle cell disease. Lancet 1993; 341: 651–653
- Strachan A. F., Noakes T. D., Kotzenberg G., Nel A. E., Beer F. C. C reactive protein concentrations during long distance running. British Medical Journal 1984; 289: 1249–1251
- Swerlick R. A., Eckman J. R., Kumar A., Jeitler M., Wick T. M. Alpha 4 beta l-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-l-dependent binding to endothelium. Blood 1993; 82: 1891–1899
- Taylor S. C., Shacks S. J., Mitchell R. A., Banks A. Serum interleukin-6 levels in the steady state of sickle cell disease. Journal of Interferon and Cytokine Research 1995; 15: 1061–1064
- Taylor S. C., Shacks S. J., Qu Z., Wiley P. Type 2 cytokine serum levels in healthy sickle cell disease patients. Journal of the National Medical Association 1997; 89: 753–757
- Ullum H., Haahr P. M., Diamant M., Palmo J., Halkjaer-Kristensen J., Pedersen B. K. Bicycle exercise enhances plasma IL-6 but does not change IL-1 alpha, IL-1 beta, IL-6, or TNF-alpha pre m-RNA in BMNC. Journal of Applied Physiology 1994; 77: 93–97
- Weight S. M., Alexander D., Jacobs P. Strenuous exercise: analogous to the acute-phase response. Clinical Science (Colch) 1991; 81: 677–683
- Weinstock C., Konig D., Harnischmacher R., Keul J., Berg A., Northoff H. Effect of exhaustive exercise stress on the cytokine response. Medicine and Science in Sports and Exercise 1997; 29: 345–354
- Werdehoff S. G., Moore R. B., Hoff C. J., Fillingim E., Hackman A. M. Elevated plasma endothelin-1 levels in sickle cell anemia: relationships to oxygen saturation and left ventricular hypertrophy. American Journal of Hematology 1998; 58: 195–199
- Yokoyama M., Hirata K., Kawashima S., Kawahara Y. Regulation of nitric oxide synthase expression by cytokine. Journal of Cardiac Failure 1996; 2: S179–S185